A recent study published in PubMed highlights molecular alterations in patients of color with advanced cutaneous and unknown primary melanomas. This research could inform targeted therapies and improve outcomes for these underrepresented populations.
molecular alterations in patients of color with advanced cutaneous and unknown primary melanomas
Original title: “Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown Primary Melanomas.”